Insider · CIK 0001650476

Payne Fletcher

Reports to the SEC for 2 companies · TORONTO

sec.gov

Transactions

Companies

Filings

CIK

0001650476

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	APTOFAptose Biosciences Inc.D Disposition to Issuer	FORMER SVP AND CFO	DDisposition to Issuer	−222 sh	$1.72	−$381.84	0
2026-06-30	APTOFAptose Biosciences Inc. · Common Stock (Option)D Disposition to Issuer	FORMER SVP AND CFO	DDisposition to Issuer	−1M sh	—	—	0
2026-06-30	APTOFAptose Biosciences Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	FORMER SVP AND CFO	DDisposition to Issuer	−200K sh	—	—	0
2026-06-30	APTOFAptose Biosciences Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	FORMER SVP AND CFO	DDisposition to Issuer	−55K sh	—	—	0
2026-06-30	APTOFAptose Biosciences Inc.D Disposition to Issuer	FORMER SVP AND CFO	DDisposition to Issuer	−22 sh	$1.72	−$37.84	0
2024-02-05	APTOFAptose Biosciences Inc. · Employee Stock Option (Right to Buy)A Award	FORMER SVP AND CFO	AAward	+55K sh	—	—	55,000
2023-01-19	APTOFAptose Biosciences Inc.A Award	FORMER SVP AND CFO	AAward	+100K sh	—	—	100,000
2023-01-19	APTOFAptose Biosciences Inc. · Employee Stock Option (Right to Buy)A Award	FORMER SVP AND CFO	AAward	+200K sh	—	—	200,000
2022-09-19	APTOFAptose Biosciences Inc.P Purchase	FORMER SVP AND CFO	PPurchase	+10K sh	$0.68	+$6,775	10,000
2022-06-27	APTOFAptose Biosciences Inc. · Common StockA Award	FORMER SVP AND CFO	AAward	+1M sh	—	—	1,000,000
2019-08-12	GYREGYRE THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+1,180 sh	$6.51	+$7,681.8	3,744
2019-02-11	GYREGYRE THERAPEUTICS, INC.A Award	Chief Financial Officer	AAward	+1,002 sh	$7.04	+$7,054.08	3,731
2019-02-04	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,503 sh	—	—	73,497
2019-02-04	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,503 sh	$4.63	+$6,958.89	3,230
2019-01-24	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+38K sh	—	—	38,000
2018-07-30	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+25K sh	—	—	25,000
2018-03-26	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−59 sh	—	—	74,941
2018-03-26	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+59 sh	$4.63	+$273.17	59
2018-01-12	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+26K sh	—	—	26,000
2017-07-11	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2015-12-17	GYREGYRE THERAPEUTICS, INC.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$2.00	+$20K	25,032
2015-10-22	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+28.6K sh	—	—	28,572
2015-10-22	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+28.6K sh	—	—	28,572
2015-10-22	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+71.4K sh	—	—	71,428
2015-08-20	GYREGYRE THERAPEUTICS, INC.J Other	Chief Financial Officer	JOther	+15K sh	—	—	15,032
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)J Other	Chief Financial Officer	JOther	+7,320 sh	—	—	7,320
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)J Other	Chief Financial Officer	JOther	+14.3K sh	—	—	14,325
2015-08-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)J Other	Chief Financial Officer	JOther	+2,440 sh	—	—	2,440

Recent filings

Accepted (ET)
Jul 14
Payne Fletcher0000912282-26-000895
SEC(opens sec.gov)
Feb 74
Payne Fletcher0000912282-24-000134
SEC(opens sec.gov)
Jan 234
Payne Fletcher0001567619-23-001162
SEC(opens sec.gov)
Sep 214
Payne Fletcher0001567619-22-017697
SEC(opens sec.gov)
Jun 284
Payne Fletcher0001567619-22-013453
SEC(opens sec.gov)
Aug 124
Payne Fletcher0001209191-19-045506
SEC(opens sec.gov)
Feb 134
Payne Fletcher0001209191-19-009885
SEC(opens sec.gov)
Feb 44
Payne Fletcher0001209191-19-006858
SEC(opens sec.gov)
Jan 284
Payne Fletcher0001209191-19-005667
SEC(opens sec.gov)
Aug 14
Payne Fletcher0001209191-18-044790
SEC(opens sec.gov)
Mar 284
Payne Fletcher0001209191-18-021896
SEC(opens sec.gov)
Jan 164
Payne Fletcher0000899243-18-001063
SEC(opens sec.gov)
Jul 124
CATALYST BIOSCIENCES, INC.0001209191-17-044901
SEC(opens sec.gov)

Companies

Address

C/O APTOSE BIOSCIENCES INC. 251 CONSUMERS ROAD, SUITE 1105

TORONTO, M2J 4R3